Safety and Efficacy of Toripalimab for Patients With Locally Advanced or Metastatic Bladder Urothelial Carcinoma
Condition(s):Bladder Urothelial CarcinomaLast Updated:September 30, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Bladder Urothelial CarcinomaLast Updated:September 30, 2020Unknown status
Condition(s):Urinary Bladder Urothelial CarcinomaLast Updated:July 29, 2022Recruiting
Condition(s):High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma; Perfusion; Complications; Intraoperative ComplicationsLast Updated:September 16, 2022Recruiting
Condition(s):Bladder Cancer; Bladder Urothelial CarcinomaLast Updated:April 20, 2022Terminated
Condition(s):Upper Tract Urinary Carcinoma; Muscle-invasive Bladder CancerLast Updated:March 29, 2022Unknown status
Condition(s):Bladder CancerLast Updated:August 4, 2022Not yet recruiting
Condition(s):Urinary Bladder NeoplasmLast Updated:December 1, 2021Terminated
Condition(s):Bladder Urothelial CarcinomaLast Updated:October 28, 2013Unknown status
Condition(s):Bladder Urothelial CancerLast Updated:February 26, 2024Recruiting
Condition(s):Urothelial CarcinomaLast Updated:July 15, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.